Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request, 75355-75356 [2013-29510]
Download as PDF
<![CDATA[
75355
Federal Register / Vol. 78, No. 238 / Wednesday, December 11, 2013 / Notices
Health Service Act) are required to
report financial data to HRSA at the
beginning and end of their grant cycle.
All Parts of the Ryan White HIV/AIDS
Program specify HRSA’s responsibilities
in the administration of grant funds.
Accurate allocation and expenditure
records of the grantees receiving Ryan
White HIV/AIDS Program funding are
critical to the implementation of the
legislation and thus are necessary for
HRSA to fulfill its responsibilities.
The forms require grantees to report
on how funds are allocated and spent on
core and non-core services, and on
various program components, such as
administration, planning and
evaluation, and quality management.
The two forms are identical in the types
of information they collect. However,
the allocation report provides data on
how grantees allocate funding at the
beginning of their grant cycle and the
second report or the expenditure reports
track actual expenditures (including
carryover dollars) at the end of their
grant cycle.
The primary purposes of these forms
are to: (1) Provide information on the
number of grant dollars spent on various
services and program components; and
(2) oversee compliance with the intent
of congressional appropriations in a
timely manner. In addition to meeting
the goal of accountability to Congress,
clients, advocacy groups, and the
general public, information collected on
these reports is critical for HRSA, state
and local grantees, and individual
providers to evaluate the effectiveness
of these programs.
Likely Respondents: All Ryan White
HIV/AIDS Program Grantees (Part A,
Part B, Part C, and Part D)
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
grantee
respondents
Program under which grantee is funded
Part
Part
Part
Part
Part
Part
Responses
per grantee
Total
responses
Average burden per
response
(in hours)
Total burden
hours
A ...................................................................................
B ...................................................................................
A MAI ...........................................................................
B MAI ...........................................................................
C ...................................................................................
D ...................................................................................
56
59
56
59
361
90
2
2
2
2
2
2
112
118
112
118
722
180
8
12
4
4
7
7
896
1,416
448
472
5,054
1,260
Total ..............................................................................
681
........................
1,362
........................
9,546
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 5, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
ACTION:
[FR Doc. 2013–29511 Filed 12–10–13; 8:45 am]
emcdonald on DSK67QTVN1PROD with NOTICES
BILLING CODE 4165–15–P
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
AGENCY:
Notice.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
SUMMARY:
Comments on this ICR should be
received within 30 days of this notice.
DATES:
VerDate Mar<15>2010
17:00 Dec 10, 2013
Jkt 232001
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Stem Cell Therapeutic Outcomes
Database.
OMB #0915–0310—Revision.
Abstract: The Stem Cell Therapeutic
and Research Act of 2005, Public Law
(Pub. L.) 109–129, as amended by the
Stem Cell Therapeutic and Research
Reauthorization Act of 2010, Public Law
111–264 (the Act), provides for the
collection and maintenance of human
blood stem cells for the treatment of
patients and research. HRSA’s
Healthcare Systems Bureau has
established the Stem Cell Therapeutic
Outcomes Database. Operation of this
database necessitates certain record
ADDRESSES:
E:\FR\FM\11DEN1.SGM
11DEN1
75356
Federal Register / Vol. 78, No. 238 / Wednesday, December 11, 2013 / Notices
keeping and reporting requirements in
order to perform the functions related to
hematopoietic stem cell transplantation
under contract to the U.S. Department of
Health and Human Services (HHS). The
Act requires the Secretary to contract for
the establishment and maintenance of
information related to patients who
have received stem cell therapeutic
products and to do so using a
standardized, electronic format. Data is
collected from transplant centers by the
Center for International Blood and
Marrow Transplant Research and is
used for ongoing analysis of transplant
outcomes. HRSA uses the information
in order to carry out its statutory
responsibilities. Information is needed
to monitor the clinical status of
transplantation and to provide the
Secretary of HHS with an annual report
of transplant center-specific survival
data. The increase in burden, as
reflected in this revised submission
request, is due to an increase in the
annual number of transplants and
increasing survivorship after
transplantation.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
ESTIMATES OF AVERAGE ANNUALIZED HOUR BURDEN
Number of
respondents
Form name
Responses
per
respondent
Total
responses
Hours per
response
Total burden
hours
Baseline Pre-Transplant Essential Data (TED) ...................
Product Form (includes Infusion, HLA, and Infectious Disease Marker inserts) ........................................................
100-Day Post-TED ...............................................................
6-Month Post-TED ...............................................................
12-Month Post-TED .............................................................
Annual Post-TED .................................................................
200
38
7,600
1
7,600
200
200
200
200
200
29
38
31
27
104
5,800
7,600
6,200
5,400
20,800
1
0.85
1
1
1
5,800
6,460
6,200
5,400
20,800
Total ..............................................................................
200
........................
53,400
........................
52,260
Dated: December 5, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–29510 Filed 12–10–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
AGENCY:
ACTION:
Notice.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:00 Dec 10, 2013
Jkt 232001
Comments on this ICR should be
received within 30 days of this notice.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Combating Autism Act Initiative
Evaluation OMB No. 0915–0335
[Revision].
Abstract: In response to the growing
need for research and resources devoted
to autism spectrum disorders (ASD) and
other developmental disabilities (DD),
the U.S. Congress passed the Combating
Autism Act (CAA) in 2006. The Act
included funding for the U.S.
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA), to
increase awareness, reduce barriers to
screening and diagnosis, promote
evidence-based interventions, and train
health care professionals to screen for,
diagnose or rule out, and provide
evidence-based interventions for ASD
DATES:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
and other DD. In 2011, the Combating
Autism Reauthorization Act (CARA)
was signed into law, reauthorizing
funding for the CAA’s programs for an
additional 3 years at the existing
funding levels. Through the CARA,
HRSA is tasked with increasing
awareness of ASD and other DD,
reducing barriers to screening and
diagnosis, promoting evidence-based
interventions, and training health care
professionals in the use of valid and
reliable screening and diagnostic tools.
Need and Proposed Use of the
Information: HRSA’s activities under
the CARA legislation are delegated to
the Maternal and Child Health Bureau
(MCHB), which is implementing the
Combating Autism Act Initiative (CAAI)
in response to the legislative mandate.
The purpose of this evaluation is to
design and implement an evaluation to
assess the effectiveness of MCHB’s
activities in meeting the goals and
objectives of the CAAI and to provide
sufficient data to inform MCHB and the
Congress as to the utility of the grant
programs funded under the Initiative.
The evaluation will focus on indicators
related to: (1) Increasing awareness of
ASD and other DD among health care
providers, other MCH professionals, and
the general public; (2) reducing barriers
to screening and diagnosis; (3)
supporting research on evidence-based
interventions; (4) promoting the
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 78, Number 238 (Wednesday, December 11, 2013)]
[Notices]
[Pages 75355-75356]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29510]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health Resources and Services Administration
(HRSA) has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received within 30 days of this
notice.
ADDRESSES: Submit your comments, including the Information Collection
Request Title, to the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to 202-395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Stem Cell Therapeutic
Outcomes Database.
OMB 0915-0310--Revision.
Abstract: The Stem Cell Therapeutic and Research Act of 2005,
Public Law (Pub. L.) 109-129, as amended by the Stem Cell Therapeutic
and Research Reauthorization Act of 2010, Public Law 111-264 (the Act),
provides for the collection and maintenance of human blood stem cells
for the treatment of patients and research. HRSA's Healthcare Systems
Bureau has established the Stem Cell Therapeutic Outcomes Database.
Operation of this database necessitates certain record
[[Page 75356]]
keeping and reporting requirements in order to perform the functions
related to hematopoietic stem cell transplantation under contract to
the U.S. Department of Health and Human Services (HHS). The Act
requires the Secretary to contract for the establishment and
maintenance of information related to patients who have received stem
cell therapeutic products and to do so using a standardized, electronic
format. Data is collected from transplant centers by the Center for
International Blood and Marrow Transplant Research and is used for
ongoing analysis of transplant outcomes. HRSA uses the information in
order to carry out its statutory responsibilities. Information is
needed to monitor the clinical status of transplantation and to provide
the Secretary of HHS with an annual report of transplant center-
specific survival data. The increase in burden, as reflected in this
revised submission request, is due to an increase in the annual number
of transplants and increasing survivorship after transplantation.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions, to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information, to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information, and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Estimates of Average Annualized Hour Burden
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Form name respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
Baseline Pre-Transplant 200 38 7,600 1 7,600
Essential Data (TED)...........
Product Form (includes Infusion, 200 29 5,800 1 5,800
HLA, and Infectious Disease
Marker inserts)................
100-Day Post-TED................ 200 38 7,600 0.85 6,460
6-Month Post-TED................ 200 31 6,200 1 6,200
12-Month Post-TED............... 200 27 5,400 1 5,400
Annual Post-TED................. 200 104 20,800 1 20,800
-------------------------------------------------------------------------------
Total....................... 200 .............. 53,400 .............. 52,260
----------------------------------------------------------------------------------------------------------------
Dated: December 5, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-29510 Filed 12-10-13; 8:45 am]
BILLING CODE 4165-15-P
